Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: quidditch	11/18/2005 12:08:41 PM
	Read Replies (1) of 10280

Just back from traveling and saw this late week GS comment: <<Market growth remains the key story in the insomnia market, up 23% in October. Lunesta gained 60 basis points of share (up to 14.7%) while the Ambien franchise lost 50 basis points of share (down to 58.8%) despite the launch of Ambien CR. The Rozerem launch remains slow though it gained 100 basis points of share this week to 1.4%.>>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next